Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis
Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

Recent & Breaking News (GREY:TBPMQ)

Tetra Bio-Pharma Shareholders Approve the Acquisition of Panag Pharma

GlobeNewswire April 18, 2019

Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer

GlobeNewswire April 11, 2019

Tetra Bio-Pharma Resumes its Phase 3 Clinical Trial Program

GlobeNewswire April 9, 2019

Tetra Bio-Pharma Announces Employment Contract Renewal of CEO Guy Chamberland

GlobeNewswire April 1, 2019

Tetra Bio-Pharma to File PPP001 With the European Medicines Agency

GlobeNewswire March 27, 2019

Tetra Bio-Pharma Names Vice-President, Clinical Programs and Medical Affairs to Its Leadership Team

GlobeNewswire March 6, 2019

Tetra Bio-Pharma and Santé Cannabis Announce Completion of the First Phase 2 Cannabis Oil Trial in Cancer and Non-Cancer Patients

GlobeNewswire March 4, 2019

Two in Three (65%) Canadians Would Take a Drug Containing Cannabis if Prescribed by a Doctor and Covered by Insurance

Canada NewsWire February 26, 2019

The Hemp Energy Drink arrives in store!

GlobeNewswire February 18, 2019

Tetra Bio-Pharma Provides Update on its Neuropathic and Chronic Pain Drug Development Program

GlobeNewswire February 12, 2019

Tetra Bio-Pharma Announces Stock Option Grants

GlobeNewswire February 8, 2019

Tetra Bio-Pharma Pursues Its Research Priorities Accelerating Other Drug Development Plans

GlobeNewswire February 7, 2019

Tetra Bio-Pharma Redefines Quality Standards for Pharmaceutical Grade Cannabis-Derived Products

GlobeNewswire February 5, 2019

Crescita Therapeutics Inc.™ and Tetra Natural Health Collaborate to Enhance Transdermal Delivery of Beta-Caryophyllene in Tetra’s Dermatology Product Portfolio

GlobeNewswire February 4, 2019

Tetra Bio-Pharma Enters into Definitive Agreement to Acquire Panag Pharma Inc.

Canada NewsWire January 30, 2019

Tetra Bio-Pharma Files Patent Application to Protect PPP001

GlobeNewswire January 28, 2019

Tetra Natural Health Adds New Leaders to its Commercial Operations

GlobeNewswire January 14, 2019

Tetra Successfully Completes Phase 1 Study With Vaporized Version of PPP001

GlobeNewswire December 20, 2018

Tetra Bio-Pharma Confirms Agreements With Multiple Suppliers

GlobeNewswire December 11, 2018

Tetra Bio-Pharma in Process of Filing Patent Application Exceeding its Data Protection Initial Assumption for its PPP001

GlobeNewswire December 6, 2018